Objective Olfactory Dysfunction Linked to Mortality in Seniors
FRIDAY, Oct. 23, 2020 -- For older adults, objective olfactory dysfunction is associated with increased mortality, according to a study published online Oct. 22 in JAMA Otolaryngology-Head & Neck Surgery.
Janet S. Choi, M.D., M.P.H., from the Keck School of Medicine at the University of Southern California in Los Angeles, and colleagues examined the association between olfactory dysfunction and all-cause five-year mortality in a cohort study involving 3,503 U.S. adults. Olfaction was assessed by self-report and with an objective measure (8-odor Pocket Smell Test).
The researchers found that the prevalence of olfactory dysfunction was 13.5 and 21.6 percent based on results of an objective smell test and based on self-report, respectively. Per 1-point decrease in smell test score, the risk for mortality increased by 18 percent in a multivariate model. The association was not significant among adults aged 40 to 64 years, but was significant among adults aged 65 years or older in association with binary and linear measures of objective olfactory dysfunction (hazard ratios, 1.95 and 1.19, respectively). No association was seen between self-reported olfactory dysfunction and mortality. After further adjustment for the cognitive assessment battery and depression among older adults, the association between objective olfactory dysfunction and mortality remained (hazard ratio, 1.18).
"This work emphasizes the importance of this special sense and shines a spotlight on its importance for the health and longevity of a rapidly growing segment of our population," write the authors of an accompanying editorial.
© 2020 HealthDay. All rights reserved.
Posted: October 2020
Read this next
TUESDAY, Nov. 24, 2020 -- Americans planning to travel out of the country should get a total of three COVID-19 tests before and after their flights, according to updated...
TUESDAY, Nov. 24, 2020 -- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection rates are generally low among children, with variation in testing and positivity...
MONDAY, Nov. 23, 2020 -- Fresh takes on the efficacy of fish oil and vitamin D, new treatments for heart failure patients, the cardiovascular effects of COVID-19, and structural...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
- Monthly Update Archive
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.